Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Indacaterol manufacturers

5 products found

Filters

5 products found

glycopyrronium bromide + indacaterol

Capsules 43 mcg + 85 mcg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #358
A pharmaceutical manufacturer based in the EU that is active in 70+ countries worldwide selling its products in the EU, Australia, Pacific region, and Asia for 30+ years. The company owns several manufacturing plants that comply with EU GMP requirements with production facilities for Rx products, OTC products, nutraceuticals, and medical devices. Its key therapy areas are diabetology, oncology, and neuropsychiatry. The company possesses several R&D centers with hundreds of patents and provides e-CTD format dossiers.

Manufacturer usually replies in 25 days

indacaterol

Inhalation powder TBD

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #13159
This company is a driving force in developing innovative treatments and technologies for a range of medical needs. Focusing on areas like psychiatry & neurology, oncology, urology, women's health, rare disease, and cell & gene therapy, they have a diverse pipeline of preclinical and clinical programs. Their technology-driven approach aims to bring patient-first solutions to market faster. While specific details about their production lines (prescription medications, over-the-counter drugs, medical devices, supplements) and GMP certifications are not provided, their commitment to research and development in key therapy areas suggests a broad scope of products. The company operates in regions like the EU and North America, emphasizing global impact.

Manufacturer usually replies in 3 days

indacaterol

Capsules 75 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
FDA, EU GMP
Manufacturer #21340
The company is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

Manufacturer usually replies in 8 days

Want to see all 5 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Glycopyrronium Bromide Manufacturers

Markets of interest

As an antispasmodic Glycopyrronium Bromide prescribed to treat some disorders of the gastrointestinal tract and to reduce salivation with some anesthetics. The substance is available for sale in the form of ampoules, solution for injection, capsules, from manufacturers in various countries including Y. The drug is provided by a wide range of Glycopyrronium Bromide suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Glycopyrronium Bromide manufacturers and distributors are based in China Bangladesh, and Turkey.

Licensing and brand names

In October 2015, Glycopyrronium Bromide was approved by the FDA for use as a standalone treatment for Chronic obstructive pulmonary disease (COPD) in the USA. The medication was approved by the EMA in the European Union in 2012. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Cuvposa, Enurev Breezhaler. One of the most popular branded versions of Glycopyrronium Bromide is manufactured and supplied by the Dutch pharmaceutical company Duchefa Farma B.V. Other manufacturing companies and distributors from India, Spain, Switzerland, Portugal, France, and Italy have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Glycopyrronium Bromide as an active ingredient.

Target supply price

The wholesale acquisition cost for Glycopyrronium Bromide injectable solution (0.2 mg/mL) is around $67 for a supply of 25 milliliters. The retail price of 85mcg + 43 mcg inhalable powder (hard capsules) N30 x 1 + 1 inhaler 46.45 € of the substance in Europe reaches EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Glycopyrronium Bromide manufacturers and suppliers that you are looking for. You can also find the dossier status of Glycopyrronium Bromide and the GMP approvals of the different variants of the medication. The product description of all Glycopyrronium Bromide suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Glycopyrronium Bromide is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible